Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alnylam Pharmaceuticals Inc (ALNY)  
$148.43 1.60 (1.07%) as of 4:30 Fri 5/31


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,030,000
Market Cap: 18.26(B)
Last Volume: 1,250,341 Avg Vol: 722,222
52 Week Range: $143.31 - $211.65
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  824
Guru Rank Value     : 0.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 76,855 102,504 247,093
Total Sell Value $0 $12,957,715 $17,713,340 $48,829,179
Total People Sold 0 7 8 9
Total Sell Transactions 0 12 18 35
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 748
  Page 22 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sharp Philip A Director   –       •      –    2013-07-02 4 A $0.00 $0 D/D 38,837 53,106     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2013-07-01 4 AS $32.00 $864,000 D/D (27,000) 7,847     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2013-07-01 4 OE $21.35 $597,450 D/D 27,000 22,847     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2013-06-17 4 AS $29.93 $707,160 D/D (23,625) 7,847     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2013-06-17 4 OE $9.14 $322,203 D/D 23,625 14,097     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2013-06-11 4 AS $31.07 $466,137 D/D (15,000) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2013-06-11 4 OE $7.10 $127,900 D/D 15,000 17,588     -
   Reid Laurence SVP and Chief Business Officer   •       –      –    2013-05-28 4 AS $30.00 $150,000 D/D (5,000) 11,681     -
   Reid Laurence SVP and Chief Business Officer   •       –      –    2013-05-28 4 OE $7.10 $35,500 D/D 5,000 16,681     -
   Greene Barry E President and COO   •       –      –    2013-05-28 4 AS $30.00 $684,660 D/D (22,822) 4,572     -
   Greene Barry E President and COO   •       –      –    2013-05-28 4 OE $0.95 $21,681 D/D 22,822 19,500     -
   Starr Kevin P Director   –       •      –    2013-03-26 4 AS $23.41 $608,577 D/D (26,000) 0     -
   Starr Kevin P Director   –       •      –    2013-03-26 4 OE $0.95 $24,700 D/D 26,000 26,000     -
   Starr Kevin P Director   –       •      –    2013-03-25 4 AS $23.56 $627,557 D/D (26,631) 0     -
   Starr Kevin P Director   –       •      –    2013-03-25 4 OE $0.95 $25,299 D/D 26,631 26,631     -
   Greene Barry E President & COO   •       –      –    2013-03-14 4 AS $25.00 $601,450 D/D (24,058) 4,572     -
   Greene Barry E President & COO   •       –      –    2013-03-14 4 OE $0.95 $22,855 D/D 24,058 28,630     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2013-03-11 4 AS $24.55 $153,415 D/D (6,250) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2013-03-11 4 OE $9.30 $58,125 D/D 6,250 18,838     -
   Greene Barry E President and COO   •       –      –    2013-03-08 4 AS $24.43 $586,270 D/D (24,000) 4,572     -
   Greene Barry E President and COO   •       –      –    2013-03-08 4 OE $0.95 $22,800 D/D 24,000 28,572     -
   Maraganore John Chief Executive Officer   •       •      –    2013-02-28 4 AS $23.50 $669,900 D/D (28,503) 18,617     -
   Maraganore John Chief Executive Officer   •       •      –    2013-02-27 4 AS $23.47 $704,019 D/D (30,000) 47,120     -
   Reid Laurence SVP, Chief Business Officer   •       –      –    2013-02-08 4 AS $25.00 $125,000 D/D (5,000) 11,681     -
   Reid Laurence SVP, Chief Business Officer   •       –      –    2013-02-08 4 OE $7.10 $35,500 D/D 5,000 16,681     -
  748 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 22 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us